Mark Bamforth
AeroLeads people directory · profile

Mark Bamforth Email & Phone Number

CEO and Board Chair at Kincell Bio
Location: Greater Boston, United States, United States 20 work roles 3 schools
1 work email found @arrantabio.com 4 phones found area 314, 617, 386, and 919 LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 4 phones

Work email m****@arrantabio.com
Direct phone (314) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
CEO and Board Chair
Location
Greater Boston, United States, United States
Company size

Who is Mark Bamforth? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Mark Bamforth is listed as CEO and Board Chair at Kincell Bio, a company with 67 employees, based in Greater Boston, United States, United States. AeroLeads shows a work email signal at arrantabio.com, phone signal with area code 314, 617, 386, 919, and a matched LinkedIn profile for Mark Bamforth.

Mark Bamforth previously worked as Member Board of Directors at Amr Newco and Member of the General Partners, Kineticos AMR Accelerator Fund I at Kineticos Ventures. Mark Bamforth holds Master Of Business Administration (Mba) from Henley Business School.

Company email context

Email format at Kincell Bio

This section adds company-level context without repeating Mark Bamforth's masked contact details.

{first}.{last}@arrantabio.com
86% confidence

AeroLeads found 1 current-domain work email signal for Mark Bamforth. Compare company email patterns before reaching out.

Profile bio

About Mark Bamforth

Mark Bamforth is a CEO and Board Chair at Kincell Bio. He possess expertise in biotechnology, biopharmaceuticals, pharmaceutical industry, technology transfer, leadership and 15 more skills. Colleagues describe him as "Mark is one of the most principled people I’ve had the pleasure of knowing in my life. He is competent, of deep intelligent, strength of character, resilient, and loyal to family and his history. Characteristics hard to find in todays world!"

Listed skills include Biotechnology, Biopharmaceuticals, Pharmaceutical Industry, Technology Transfer, and 16 others.

Current workplace

Mark Bamforth's current company

Company context helps verify the profile and gives searchers a useful next step.

Kincell Bio
Kincell Bio
CEO and Board Chair
Boston, MA, US
Website
Employees
67
AeroLeads page
20 roles · 40 years

Mark Bamforth work experience

A career timeline built from the work history available for this profile.

Member Board Of Directors

Current
Amr Newco

Driving innovation in antibacterial drug discovery, our AMR NewCo, created by Kineticos through its AMR Accelerator Fund (KAMRA), is developing a new class of broad spectrum antibacterials to treat drug resistant infections. Building upon decades of groundbreaking research from one of the world’s leading Universities, our team has developed a novel class.

May 2024 - Present

Member Of The General Partners, Kineticos Amr Accelerator Fund I

Current
Kineticos Ventures

Kineticos AMR Accelerator (KAMRA) Fund I seeks to invest in early-stage anti-microbial resistance (AMR) businesses with founders who have created unique, innovative and know-how protected products and services to address this global healthcare challenge.

Jul 2023 - Present

Founder

Current
Thairm Bio

Thairm Bio is an investor in life science entrepreneurs and disruptive companies

May 2022 - Present

Operating Partner

Wellesley, MA, US

Ampersand was founded in the late 1980s and began investing in healthcare in the early 1990s. Today, Ampersand is focused exclusively on growth equity investments in lower middle market healthcare companies. We are typically the first institutional investor in founder-owned businesses, where we work with the entrepreneur to help take the company to the.

Jul 2018 - Jan 2023

Trustee

Current

Glasgow, Scotland, GB

Trustee of a charity which aims to increase leadership talent in Scottish businesses

2007 - Present ~19 yrs 4 mos

Venture Partner

Current
Kineticos Life Sciences

Kineticos Ventures invests in biotechs striving to disrupt how drugs are developed, diseases are diagnosed, and patients are treated. The Kineticos Ventures fund focuses on significant, unmet medical needs in oncology, neurosciences, and rare diseases, utilizing disruptive technologies such as cell and gene therapy, gene editing, and mRNA/RNAi, all.

Dec 2021 - Present

Board Member

Morrisville, North Carolina, US

Mar 2021 - Apr 2023

Exec. Chair & Ceo

Watertown, MA, US

Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies. Our dedicated team, state-of-the-art facilities, and unparalleled expertise are crucial for advancing products from development to.

Aug 2019 - Apr 2022

Board Member

Cambridge, Massachusetts, US

Board Member of MassBio, which represents the biotech industry in MA

2002 - Feb 2021

President & Ceo

Cambridge, Massachusetts, US

Brammer Bio is a CDMO focused on providing process development, clinical, and commercial supply of viral vector and cell and gene therapy products, enabling the delivery of novel medicines and improving patient health. We have a highly skilled team of scientists with the development, manufacturing and analytical expertise from 100 client projects that is.

Mar 2015 - Jul 2019

President & Ceo

St. Louis, MO, US

Mark Bamforth founded and led Gallus BioPharmaceuticals, a premier contract manufacturer, to deliver clinical and commercial biopharmaceuticals in 2010. Gallus began with the acquisition of a world-class facility with an outstanding team in St. Louis, MO, in 2011, making two lead commercial products for Janssen (J&J). Since then, Gallus grew strongly.

Sep 2010 - Mar 2015

Svp, Corporate Operations & Pharmaceuticals

Paris, France, FR

Global manufacturing operations leader and corporate officer

Apr 1988 - Sep 2010

Chemical Engineer

Whitbread Plc

QC of beer and biotech project leader

1986 - 1988 ~2 yrs

Petroleum Engineer

Britoil Plc

Offshore oil exploration and production

Aug 1984 - Sep 1986
3 education records

Mark Bamforth education

Master Of Business Administration (Mba)

Henley Business School

Bachelor'S Degree, Chemical Engineering

University Of Strathclyde

Education record

Shawlands Academy, Glasgow
FAQ

Frequently asked questions about Mark Bamforth

Quick answers generated from the profile data available on this page.

What company does Mark Bamforth work for?

Mark Bamforth works for Kincell Bio.

What is Mark Bamforth's role at Kincell Bio?

Mark Bamforth is listed as CEO and Board Chair at Kincell Bio.

What is Mark Bamforth's email address?

AeroLeads has found 1 work email signal at @arrantabio.com for Mark Bamforth at Kincell Bio.

What is Mark Bamforth's phone number?

AeroLeads has found 4 phone signal(s) with area code 314, 617, 386, 919 for Mark Bamforth at Kincell Bio.

Where is Mark Bamforth based?

Mark Bamforth is based in Greater Boston, United States, United States while working with Kincell Bio.

What companies has Mark Bamforth worked for?

Mark Bamforth has worked for Kincell Bio, Amr Newco, Kineticos Ventures, Thairm Bio, and Ampersand Capital Partners.

How can I contact Mark Bamforth?

You can use AeroLeads to view verified contact signals for Mark Bamforth at Kincell Bio, including work email, phone, and LinkedIn data when available.

What schools did Mark Bamforth attend?

Mark Bamforth holds Master Of Business Administration (Mba) from Henley Business School.

What skills is Mark Bamforth known for?

Mark Bamforth is listed with skills including Biotechnology, Biopharmaceuticals, Pharmaceutical Industry, Technology Transfer, Leadership, Life Sciences, Strategic Planning, and Lifesciences.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.